Equitable Holdings
SLS icon

Equitable Holdings’s SELLAS Life Sciences SLS Stock Holding History

Equitable Holdings’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-32,060
Closed -$121K – 1751
2025
Q4 		$121K Buy
32,060
+5,000
+18% +$9.72K ﹤0.01% 1532
2025
Q3 		$43.6K Buy
27,060
+10,000
+59% +$17.8K ﹤0.01% 1510
2025
Q2 		$37.4K Buy
17,060
+5,000
+41% +$7.67K ﹤0.01% 1442
2025
Q1 		$13K Hold
12,060
– – ﹤0.01% 1333
2024
Q4 		$12.5K Hold
12,060
– – ﹤0.01% 1261
2024
Q3 		$15.1K Sell
12,060
-197,940
-94% -$242K ﹤0.01% 1255
2024
Q2 		$250K Buy
210,000
+10,000
+5% +$13.6K ﹤0.01% 1049
2024
Q1 		$202K Buy
200,000
+35,000
+21% +$29.4K ﹤0.01% 1093
2023
Q4 		$175K Buy
165,000
+30,000
+22% +$32.5K ﹤0.01% 1076
2023
Q3 		$221K Hold
135,000
– – ﹤0.01% 971
2023
Q2 		$212K Buy
135,000
+5,000
+4% +$8.03K ﹤0.01% 969
2023
Q1 		$186K Buy
130,000
+17,000
+15% +$42.1K ﹤0.01% 933
2022
Q4 		$267K Buy
113,000
+3,000
+3% +$8.41K ﹤0.01% 768
2022
Q3 		$222K Hold
110,000
– – ﹤0.01% 774
2022
Q2 		$245K Buy
110,000
+6,000
+6% +$17.6K ﹤0.01% 755
2022
Q1 		$695K Buy
104,000
+2,000
+2% +$11.7K 0.01% 500
2021
Q4 		$564K Buy
102,000
+2,000
+2% +$15.1K 0.01% 541
2021
Q3 		$916K Buy
100,000
+5,700
+6% +$52.9K 0.02% 403
2021
Q2 		$1.05M Hold
94,300
– – 0.02% 360
2021
Q1 		$805K Hold
94,300
– – 0.02% 399
2020
Q4 		$548K Buy
94,300
+34,000
+56% +$136K 0.01% 439
2020
Q3 		$160K Buy
+60,300
New +$165K ﹤0.01% 602

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Equitable Holdings's SLS Position: Q1 2026 in Review

Equitable Holdings sold out of SELLAS Life Sciences (SLS) in Q1 2026, closing a stake of 32,060 shares — an estimated $121K sold.

Equitable Holdings first reported a position in SLS in Q3 2020 and held it in 22 quarters. The position peaked at $1.05M in Q2 2021. 160 funds tracked by Wall St. Rank hold SLS as of Q1 2026.

  • Equitable Holdings reported no remaining SELLAS Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Equitable Holdings sold 32,060 SELLAS Life Sciences shares in Q1 2026, an estimated $121K.
  • Equitable Holdings first reported a position in SELLAS Life Sciences in Q3 2020 and held it in 22 quarters.
  • Equitable Holdings's SELLAS Life Sciences position peaked at $1.05M in Q2 2021.
  • 160 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2026.

Based on Equitable Holdings's 13F filing for Q1 2026, filed 15 May 2026.